Segment disclosures

Company overview

ADIA MED, INC.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

34 dimension combinations 128 retained observations 8 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Adia Labs

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ADIA:AdiaLabsMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-09-30442475 USD20261116Open filing evidence
2026-01-01 – 2026-06-30226990 USD20260813Open filing evidence
2026-01-01 – 2026-03-3171425 USD20260515Open filing evidence
2025-01-01 – 2025-12-31448888 USD20260331Open filing evidence
2025-01-01 – 2025-09-30317698 USD20261116Open filing evidence
2025-01-01 – 2025-06-3088788 USD20260813Open filing evidence
2025-01-01 – 2025-03-310 USD20260515Open filing evidence
2024-01-01 – 2024-12-310 USD20260331Open filing evidence

Adia Labs · Medical Procedures

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ADIA:AdiaLabsMember;srt:ProductOrServiceAxis=ADIA:MedicalProceduresMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-09-300 USD20261116Open filing evidence
2026-01-01 – 2026-06-300 USD20260813Open filing evidence
2026-01-01 – 2026-03-310 USD20260515Open filing evidence
2025-01-01 – 2025-09-300 USD20261116Open filing evidence
2025-01-01 – 2025-06-300 USD20260813Open filing evidence
2025-01-01 – 2025-03-310 USD20260515Open filing evidence

Adia Labs · Sales Of Biologics Net Of Discounts And Refunds

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ADIA:AdiaLabsMember;srt:ProductOrServiceAxis=ADIA:SalesOfBiologicsNetOfDiscountsAndRefundsMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-09-30433260 USD20261116Open filing evidence
2026-01-01 – 2026-06-30221525 USD20260813Open filing evidence
2025-01-01 – 2025-09-30313010 USD20261116Open filing evidence
2025-01-01 – 2025-06-3087500 USD20260813Open filing evidence

Adia Labs · Sales Of Prducts And Services

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ADIA:AdiaLabsMember;srt:ProductOrServiceAxis=ADIA:SalesOfPrductsAndServicesMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-03-3169775 USD20260515Open filing evidence
2025-01-01 – 2025-12-31448888 USD20260331Open filing evidence
2025-01-01 – 2025-03-310 USD20260515Open filing evidence
2024-01-01 – 2024-12-310 USD20260331Open filing evidence

Adia Labs · Sales Of Supplements

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ADIA:AdiaLabsMember;srt:ProductOrServiceAxis=ADIA:SalesOfSupplementsMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-09-300 USD20261116Open filing evidence
2025-01-01 – 2025-06-300 USD20260813Open filing evidence
2025-01-01 – 2025-03-310 USD20260515Open filing evidence

Adia Labs · Shipping And Delivery

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ADIA:AdiaLabsMember;srt:ProductOrServiceAxis=ADIA:ShippingAndDeliveryMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-09-309215 USD20261116Open filing evidence
2026-01-01 – 2026-06-305465 USD20260813Open filing evidence
2026-01-01 – 2026-03-311650 USD20260515Open filing evidence
2025-01-01 – 2025-09-304688 USD20261116Open filing evidence
2025-01-01 – 2025-03-310 USD20260515Open filing evidence

Adia Labs · Service

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ADIA:AdiaLabsMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-09-300 USD20261116Open filing evidence
2025-01-01 – 2025-06-301288 USD20260813Open filing evidence

Adia Med

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ADIA:AdiaMedMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-09-30576770 USD20261116Open filing evidence
2026-01-01 – 2026-06-30434670 USD20260813Open filing evidence
2026-01-01 – 2026-03-31104850 USD20260515Open filing evidence
2025-01-01 – 2025-12-31245960 USD20260331Open filing evidence
2025-01-01 – 2025-09-30198600 USD20261116Open filing evidence
2025-01-01 – 2025-06-3096700 USD20260813Open filing evidence
2025-01-01 – 2025-03-3170700 USD20260515Open filing evidence
2024-01-01 – 2024-12-310 USD20260331Open filing evidence

Adia Med · Medical Procedures

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ADIA:AdiaMedMember;srt:ProductOrServiceAxis=ADIA:MedicalProceduresMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-09-30576770 USD20261116Open filing evidence
2026-01-01 – 2026-06-30434670 USD20260813Open filing evidence
2026-01-01 – 2026-03-31104850 USD20260515Open filing evidence
2025-01-01 – 2025-09-30198600 USD20261116Open filing evidence
2025-01-01 – 2025-06-3096700 USD20260813Open filing evidence
2025-01-01 – 2025-03-3170700 USD20260515Open filing evidence

Adia Med · Sales Of Biologics Net Of Discounts And Refunds

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ADIA:AdiaMedMember;srt:ProductOrServiceAxis=ADIA:SalesOfBiologicsNetOfDiscountsAndRefundsMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-09-300 USD20261116Open filing evidence
2026-01-01 – 2026-06-300 USD20260813Open filing evidence
2025-01-01 – 2025-09-300 USD20261116Open filing evidence
2025-01-01 – 2025-06-300 USD20260813Open filing evidence

Adia Med · Sales Of Prducts And Services

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ADIA:AdiaMedMember;srt:ProductOrServiceAxis=ADIA:SalesOfPrductsAndServicesMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-03-310 USD20260515Open filing evidence
2025-01-01 – 2025-12-31245960 USD20260331Open filing evidence
2025-01-01 – 2025-03-310 USD20260515Open filing evidence
2024-01-01 – 2024-12-310 USD20260331Open filing evidence

Adia Med · Sales Of Supplements

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ADIA:AdiaMedMember;srt:ProductOrServiceAxis=ADIA:SalesOfSupplementsMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-09-300 USD20261116Open filing evidence
2025-01-01 – 2025-06-300 USD20260813Open filing evidence
2025-01-01 – 2025-03-310 USD20260515Open filing evidence

Adia Med · Shipping And Delivery

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ADIA:AdiaMedMember;srt:ProductOrServiceAxis=ADIA:ShippingAndDeliveryMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-09-300 USD20261116Open filing evidence
2026-01-01 – 2026-06-300 USD20260813Open filing evidence
2026-01-01 – 2026-03-310 USD20260515Open filing evidence
2025-01-01 – 2025-09-300 USD20261116Open filing evidence
2025-01-01 – 2025-03-310 USD20260515Open filing evidence

Adia Med · Service

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ADIA:AdiaMedMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-09-300 USD20261116Open filing evidence
2025-01-01 – 2025-06-300 USD20260813Open filing evidence

Biolete

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ADIA:BioleteMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-09-300 USD20261116Open filing evidence
2026-01-01 – 2026-06-300 USD20260813Open filing evidence
2026-01-01 – 2026-03-310 USD20260515Open filing evidence
2025-01-01 – 2025-12-313393 USD20260331Open filing evidence
2025-01-01 – 2025-09-303393 USD20261116Open filing evidence
2025-01-01 – 2025-06-302155 USD20260813Open filing evidence
2025-01-01 – 2025-03-311064 USD20260515Open filing evidence
2024-01-01 – 2024-12-316380 USD20260331Open filing evidence

Biolete · Medical Procedures

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ADIA:BioleteMember;srt:ProductOrServiceAxis=ADIA:MedicalProceduresMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-09-300 USD20261116Open filing evidence
2026-01-01 – 2026-06-300 USD20260813Open filing evidence
2026-01-01 – 2026-03-310 USD20260515Open filing evidence
2025-01-01 – 2025-09-300 USD20261116Open filing evidence
2025-01-01 – 2025-06-300 USD20260813Open filing evidence
2025-01-01 – 2025-03-310 USD20260515Open filing evidence

Biolete · Sales Of Biologics Net Of Discounts And Refunds

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ADIA:BioleteMember;srt:ProductOrServiceAxis=ADIA:SalesOfBiologicsNetOfDiscountsAndRefundsMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-09-300 USD20261116Open filing evidence
2026-01-01 – 2026-06-300 USD20260813Open filing evidence
2025-01-01 – 2025-09-300 USD20261116Open filing evidence
2025-01-01 – 2025-06-300 USD20260813Open filing evidence

Biolete · Sales Of Prducts And Services

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ADIA:BioleteMember;srt:ProductOrServiceAxis=ADIA:SalesOfPrductsAndServicesMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-03-310 USD20260515Open filing evidence
2025-01-01 – 2025-12-313393 USD20260331Open filing evidence
2025-01-01 – 2025-03-310 USD20260515Open filing evidence
2024-01-01 – 2024-12-316380 USD20260331Open filing evidence

Biolete · Sales Of Supplements

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ADIA:BioleteMember;srt:ProductOrServiceAxis=ADIA:SalesOfSupplementsMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-09-303393 USD20261116Open filing evidence
2025-01-01 – 2025-06-302155 USD20260813Open filing evidence
2025-01-01 – 2025-03-311064 USD20260515Open filing evidence

Biolete · Shipping And Delivery

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ADIA:BioleteMember;srt:ProductOrServiceAxis=ADIA:ShippingAndDeliveryMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-09-300 USD20261116Open filing evidence
2026-01-01 – 2026-06-300 USD20260813Open filing evidence
2026-01-01 – 2026-03-310 USD20260515Open filing evidence
2025-01-01 – 2025-09-300 USD20261116Open filing evidence
2025-01-01 – 2025-03-310 USD20260515Open filing evidence

Biolete · Service

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ADIA:BioleteMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-09-300 USD20261116Open filing evidence
2025-01-01 – 2025-06-300 USD20260813Open filing evidence

Corporate And Other

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateAndOtherMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-09-300 USD20261116Open filing evidence
2025-01-01 – 2025-09-302267 USD20261116Open filing evidence

Corporate And Other · Medical Procedures

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateAndOtherMember;srt:ProductOrServiceAxis=ADIA:MedicalProceduresMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-09-300 USD20261116Open filing evidence
2025-01-01 – 2025-09-300 USD20261116Open filing evidence

Corporate And Other · Sales Of Biologics Net Of Discounts And Refunds

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateAndOtherMember;srt:ProductOrServiceAxis=ADIA:SalesOfBiologicsNetOfDiscountsAndRefundsMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-09-300 USD20261116Open filing evidence
2025-01-01 – 2025-09-300 USD20261116Open filing evidence

Corporate And Other · Sales Of Supplements

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateAndOtherMember;srt:ProductOrServiceAxis=ADIA:SalesOfSupplementsMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-09-300 USD20261116Open filing evidence

Corporate And Other · Shipping And Delivery

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateAndOtherMember;srt:ProductOrServiceAxis=ADIA:ShippingAndDeliveryMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-09-300 USD20261116Open filing evidence
2025-01-01 – 2025-09-300 USD20261116Open filing evidence

Corporate And Other · Service

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateAndOtherMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-09-302267 USD20261116Open filing evidence

Corporate

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-06-300 USD20260813Open filing evidence
2026-01-01 – 2026-03-310 USD20260515Open filing evidence
2025-01-01 – 2025-12-312267 USD20260331Open filing evidence
2025-01-01 – 2025-06-302267 USD20260813Open filing evidence
2025-01-01 – 2025-03-310 USD20260515Open filing evidence
2024-01-01 – 2024-12-310 USD20260331Open filing evidence

Corporate · Medical Procedures

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateMember;srt:ProductOrServiceAxis=ADIA:MedicalProceduresMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-06-300 USD20260813Open filing evidence
2026-01-01 – 2026-03-310 USD20260515Open filing evidence
2025-01-01 – 2025-06-300 USD20260813Open filing evidence
2025-01-01 – 2025-03-310 USD20260515Open filing evidence

Corporate · Sales Of Biologics Net Of Discounts And Refunds

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateMember;srt:ProductOrServiceAxis=ADIA:SalesOfBiologicsNetOfDiscountsAndRefundsMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-06-300 USD20260813Open filing evidence
2025-01-01 – 2025-06-300 USD20260813Open filing evidence

Corporate · Sales Of Prducts And Services

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateMember;srt:ProductOrServiceAxis=ADIA:SalesOfPrductsAndServicesMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-03-310 USD20260515Open filing evidence
2025-01-01 – 2025-12-312267 USD20260331Open filing evidence
2025-01-01 – 2025-03-310 USD20260515Open filing evidence
2024-01-01 – 2024-12-310 USD20260331Open filing evidence

Corporate · Sales Of Supplements

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateMember;srt:ProductOrServiceAxis=ADIA:SalesOfSupplementsMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-06-300 USD20260813Open filing evidence
2025-01-01 – 2025-03-310 USD20260515Open filing evidence

Corporate · Shipping And Delivery

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateMember;srt:ProductOrServiceAxis=ADIA:ShippingAndDeliveryMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-06-300 USD20260813Open filing evidence
2026-01-01 – 2026-03-310 USD20260515Open filing evidence
2025-01-01 – 2025-03-310 USD20260515Open filing evidence

Corporate · Service

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-06-302267 USD20260813Open filing evidence